Home › NDC Lookup › RxCUI directory › RxCUI 2678972

{180 (danicopan 100 MG Oral Tablet) } Pack — RxCUI 2678972

RxNorm drug concept · Generic pack
RxCUI 2678972 Generic pack · GPCK ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2678972
Official name{180 (danicopan 100 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asdanicopan 200 MG Dose, 2 Bottle Kit
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How {180 (danicopan 100 MG Oral Tablet) } Pack Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {180 (danicopan 100 MG Oral Tablet) } Pack RxCUI 2678972

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Danicopan 2678952
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Voydeya 2678958
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Danicopan Oral Tablet 2678956
    • Danicopan Oral Product 2678954
    • Danicopan Pill 2678955
    • Danicopan Oral Tablet [Voydeya] 2678962
    • Voydeya Oral Product 2678960
    • Voydeya Pill 2678961
    • Pack 746839
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Danicopan 100 MG Oral Tablet SCD · 2678965
  • Danicopan 100 MG SCDC · 2678964
  • Danicopan Oral Tablet SCDF · 2678956
  • Danicopan Oral Product SCDG · 2678954
  • Danicopan Pill SCDG · 2678955

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2678972 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
25682-0043-92 2 BOTTLE in 1 CARTON (25682-043-92) / 90 TABLET, FILM COATE... Voydeya Alexion Pharmaceuticals Inc. 2024-03-29
25682-0046-92 1 KIT in 1 CARTON (25682-046-92) * 90 TABLET, FILM COATED... Voydeya Alexion Pharmaceuticals Inc. 2024-03-29
Observed labelers: Alexion Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.